Related Experiment Videos

CVT-301 for Parkinson's disease: dose and effect size issues

Olivier Rascol1

  • 1Centre d'Investigation Clinique, Services de Neurologie et de Pharmacologie Clinique, Réseau NS-PARK/FCRIN et Centre COEN NeuroToul, Centre Hospitalier Universitaire de Toulouse, Institut National de la Santé et de la Recherche Médicale, University of Toulouse, 31300 Toulouse, France.

The Lancet. Neurology
|January 22, 2019
PubMed
Summary

No abstract available in PubMed .

Related Concept Videos